These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8259163)

  • 21. Weathering the HRT storm.
    Powledge TM
    Sci Aging Knowledge Environ; 2003 Sep; 2003(38):NF18. PubMed ID: 14508059
    [No Abstract]   [Full Text] [Related]  

  • 22. The Women's Health Initiative: a heart-to-HRT conversation.
    Fitzpatrick LA; Litin SC; Bell MR
    Mayo Clin Proc; 2000 Jun; 75(6):559-61. PubMed ID: 10852415
    [No Abstract]   [Full Text] [Related]  

  • 23. The view of The International Menopause Society on the Women's Health Initiative.
    Schneider HP;
    Climacteric; 2002 Sep; 5(3):211-6. PubMed ID: 12419078
    [No Abstract]   [Full Text] [Related]  

  • 24. NIH and WHI: time for a mea culpa and steps beyond.
    Utian WH
    Menopause; 2007; 14(6):1056-9. PubMed ID: 17975521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rashomon revisited: two views of monitoring the Women's Health Initiative trials.
    Goodman SN
    Clin Trials; 2007; 4(3):205-6. PubMed ID: 17715245
    [No Abstract]   [Full Text] [Related]  

  • 26. Women's health after WHI.
    Kenemans P
    Maturitas; 2005 May; 51(1):1-3. PubMed ID: 15883101
    [No Abstract]   [Full Text] [Related]  

  • 27. Women's cognitive health: postmenopausal dementia and the women's health initiative memory study.
    Klein KP; Rapp SR
    Womens Health Issues; 2004; 14(3):71-4. PubMed ID: 15193634
    [No Abstract]   [Full Text] [Related]  

  • 28. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
    Hillman JJ; Zuckerman IH; Lee E
    J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why should we include women and minorities in randomized controlled trials?
    Weijer C; Crouch RA
    J Clin Ethics; 1999; 10(2):100-6. PubMed ID: 10633280
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
    Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Getting to the HRT of the matter.
    Johns Hopkins Med Lett Health After 50; 2002 Jul; 14(5):4-5, 7. PubMed ID: 12154800
    [No Abstract]   [Full Text] [Related]  

  • 33. Hormone replacement therapy and coronary artery disease: buried alive?
    Bahl VK; Naik N
    Indian Heart J; 2002; 54(1):23-30. PubMed ID: 11999084
    [No Abstract]   [Full Text] [Related]  

  • 34. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
    Haskell SG
    J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [What to think of postmenopausal hormone replacement therapy after 2002? ].
    Ringa V; Uzan S
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 1):86-9. PubMed ID: 12718317
    [No Abstract]   [Full Text] [Related]  

  • 36. HRT: forever or never?
    Corson SL
    Int J Fertil Womens Med; 2002; 47(4):150-1. PubMed ID: 12199410
    [No Abstract]   [Full Text] [Related]  

  • 37. The Women's Health Initiative study: perspectives and implications for clinical practice.
    Hammond CB
    Rev Endocr Metab Disord; 2005 May; 6(2):93-9. PubMed ID: 15843880
    [No Abstract]   [Full Text] [Related]  

  • 38. [Conjugated estrogen-gestagen does not reduce cardiovascular morbidity. Were these findings (in the Women's Health Initiative study) really unexpected?].
    Henriksson P
    Lakartidningen; 2002 Nov; 99(47):4716-9. PubMed ID: 12523045
    [No Abstract]   [Full Text] [Related]  

  • 39. WHI estrogen-only arm is canceled.
    Speroff L
    Maturitas; 2004 May; 48(1):3-4. PubMed ID: 15223100
    [No Abstract]   [Full Text] [Related]  

  • 40. The complex interplay of vasomotor symptoms, hormone therapy, and cardiovascular risk.
    Allison MA; Manson JE
    Menopause; 2009; 16(4):619-20. PubMed ID: 19503007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.